3-amino-2-methyl-8-phenylmethoxyimidazo(1,2-a)pyrazine has been researched along with cyclic gmp in 1 studies
| Studies (3-amino-2-methyl-8-phenylmethoxyimidazo(1,2-a)pyrazine) | Trials (3-amino-2-methyl-8-phenylmethoxyimidazo(1,2-a)pyrazine) | Recent Studies (post-2010) (3-amino-2-methyl-8-phenylmethoxyimidazo(1,2-a)pyrazine) | Studies (cyclic gmp) | Trials (cyclic gmp) | Recent Studies (post-2010) (cyclic gmp) |
|---|---|---|---|---|---|
| 8 | 0 | 0 | 22,346 | 333 | 4,062 |
| Protein | Taxonomy | 3-amino-2-methyl-8-phenylmethoxyimidazo(1,2-a)pyrazine (IC50) | cyclic gmp (IC50) |
|---|---|---|---|
| Phosphodiesterase | Bos taurus (cattle) | 0.1 | |
| cGMP-inhibited 3',5'-cyclic phosphodiesterase B | Homo sapiens (human) | 2.4 | |
| cGMP-inhibited 3',5'-cyclic phosphodiesterase A | Homo sapiens (human) | 2.4 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arnal, F; Hill, NS; Klinger, JR; Petit, RD; Warburton, RR; Wrenn, DS | 1 |
1 other study(ies) available for 3-amino-2-methyl-8-phenylmethoxyimidazo(1,2-a)pyrazine and cyclic gmp
| Article | Year |
|---|---|
Neutral endopeptidase inhibition attenuates development of hypoxic pulmonary hypertension in rats.
Topics: Animals; Atrial Natriuretic Factor; Blood Pressure; Chronic Disease; Cyclic GMP; Dioxolanes; Dipeptides; Hypertension, Pulmonary; Hypertrophy, Right Ventricular; Hypoxia; Imidazoles; Male; Muscle, Smooth, Vascular; Myocardium; Neprilysin; Pyrazines; Rats; Rats, Sprague-Dawley; RNA, Messenger | 1993 |